Page last updated: 2024-10-17

cytosine and Nasopharyngeal Neoplasms

cytosine has been researched along with Nasopharyngeal Neoplasms in 6 studies

Nasopharyngeal Neoplasms: Tumors or cancer of the NASOPHARYNX.

Research Excerpts

ExcerptRelevanceReference
"The effect of the antiviral agent (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xenografts in athymic mice."7.70The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. ( De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R, 1998)
"The effect of the antiviral agent (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine (cidofovir) on the EBV-associated tumor nasopharyngeal carcinoma (NPC) was evaluated in NPC xenografts in athymic mice."3.70The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice. ( De Clercq, E; Neyts, J; Pagano, JS; Raab-Traub, N; Sadler, R, 1998)

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's5 (83.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, H1
Zhang, L1
Niu, Z1
Zhou, M1
Peng, C1
Li, X1
Deng, T1
Shi, L1
Tan, Y1
Li, G1
Abdulkarim, B1
Sabri, S1
Zelenika, D1
Deutsch, E1
Frascogna, V1
Klijanienko, J1
Vainchenker, W1
Joab, I1
Bourhis, J1
Wakisaka, N2
Yoshizaki, T2
Raab-Traub, N3
Pagano, JS3
Kondo, S1
Murono, S2
Shimizu, Y1
Nakashima, M1
Tsuji, A1
Furukawa, M1
Neyts, J1
Sadler, R1
De Clercq, E1

Other Studies

6 other studies available for cytosine and Nasopharyngeal Neoplasms

ArticleYear
Promoter methylation inhibits BRD7 expression in human nasopharyngeal carcinoma cells.
    BMC cancer, 2008, Sep-08, Volume: 8

    Topics: Base Sequence; Binding Sites; Carcinoma; Cell Line, Tumor; Chromosomal Proteins, Non-Histone; CpG Is

2008
Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.
    Oncogene, 2003, Apr-17, Volume: 22, Issue:15

    Topics: Animals; Antiviral Agents; Apoptosis; bcl-2-Associated X Protein; Burkitt Lymphoma; Carcinoma; Caspa

2003
Ribonucleotide reductase inhibitors enhance cidofovir-induced apoptosis in EBV-positive nasopharyngeal carcinoma xenografts.
    International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Interactions; Enzyme

2005
Treatment of locally recurrent Epstein-Barr virus-associated nasopharyngeal carcinoma using the anti-viral agent cidofovir.
    Journal of medical virology, 2008, Volume: 80, Issue:5

    Topics: Adult; Antineoplastic Agents; Antiviral Agents; Cidofovir; Cytosine; Epstein-Barr Virus Infections;

2008
The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine] has pronounced activity against nasopharyngeal carcinoma grown in nude mice.
    Cancer research, 1998, Feb-01, Volume: 58, Issue:3

    Topics: Adolescent; Animals; Antiviral Agents; Apoptosis; Carcinoma; Cidofovir; Cytosine; Drug Screening Ass

1998
Prevention and inhibition of nasopharyngeal carcinoma growth by antiviral phosphonated nucleoside analogs.
    Cancer research, 2001, Nov-01, Volume: 61, Issue:21

    Topics: Adenine; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Division; Cidofovir; Cytosine; E

2001